Instrument Inactif

Autres langues Rasna Therapeutics, Inc. Other OTC

Actions

RASP

US7538881068

Recherche biotechnologique et médicale

Autres langues

20/05/24	Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
10/04/24	Actavia Life Sciences : Change in Certifying Accountants - Form 8-K
16/02/24	Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
05/01/24	Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
05/01/24	Actavia Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt
14/08/23	Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
15/05/23	Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
02/03/23	RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
02/03/23	Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
09/02/23	RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
09/02/23	Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
09/02/23	Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
24/01/23	Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K
23/01/23	RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
20/12/22	RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
22/08/22	RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
22/08/22	Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
21/06/22	RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
21/06/22	Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
16/06/22	RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
16/06/22	Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021
10/06/22	Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)
10/06/22	RASNA THERAPEUTICS INC. - 10-K/A - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
10/06/22	Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
24/05/22	Rasna Therapeutics : Unregistered Sales of Equity Securities - Form 8-K